No matter where you live, your impact can go even further when you #GiveBIG to Grameen Foundation to help poor women and families around the world. Join us on May 3rd, 2016 as we partner with Seattle Foundation and thousands of nonprofits around the United States for a one-day online fundraiser designed to maximize the impact of your donation.
Grameen Foundation is a global nonprofit organization that harnesses the power of mobile technology to deliver a vital mix of financial, agricultural, and health services and information to the world's poorest people.
Grameen Foundation 1101 15th St. NW, 3rd Floor Washington, DC 20005
Thank you so much for your past support of the Alzheimer's Association. I'm reaching out with a very exciting opportunity to make your gift go twice as far in the fight against Alzheimer's disease.
A foundation, that wishes to remain anonymous, has agreed to give $600,000 to the Alzheimer's Association if we can raise that same amount by May 31.
Your gift today can be matched dollar for dollar: $35 → $70 $60 → $120 $120 → $240
This foundation has a long-standing history of supporting organizations that benefit and inspire local communities, and this gift will enhance our local care and support services. Your generous gift today can go twice as far toward our mission to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.
Our Spring Matching Gift Challenge is a critical opportunity to make one gift and have twice the impact. When you donate today, your gift of $35 can become $70, a gift of $60 can become $120 — or your especially generous gift of $120 can become $240.
With more than 5 million people in the United States living with Alzheimer's disease, your support of this limited-time opportunity is so important. Please help us make our Spring Matching Gift Challenge a success with a generous donation today. Thank you.
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's disease® .
Alzheimer's Association awards $4.3 million for new phase of landmark prevention trial
The Alzheimer's Association has announced a $4.3 million research grant for a new phase of the Dominantly Inherited Alzheimer's Network Trials Unit (DIAN-TU) known as DIAN-TU Next Generation (NexGen). This award will accelerate the testing of potential Alzheimer's therapies and a new diagnostic approach in people with genetically based, younger-onset Alzheimer's disease using an innovative trial design that is being applied to the disease for the first time.
Register today to participate in The Longest Day on June 20
An estimated 47 million people worldwide, including more than 5 million Americans, are living with Alzheimer's disease and other dementias. You can honor them by signing up for The Longest Day®, a sunrise-to-sunset fundraising event taking place June 20. Your efforts will enhance care and support and advance research toward methods of treatment, prevention and, ultimately, a cure.
Families should talk openly about driving and Alzheimer's disease
Driving demands quick reaction time and fast decision making — because of this, a person with Alzheimer's or another dementia will eventually become unable to drive. Making decisions about when it's time to stop driving can be difficult, but dealing with the issue early on can help ease the transition.
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.